Report · estimate
Assess Skin Mole for Melanoma vs. Benign via Visual and Tactile Examination
“Assess whether a mole on a patient's skin is melanoma or benign through visual and tactile examination”
Summary · Clinical dermoscopic and tactile assessment of a skin lesion to determine whether it is melanoma or benign — a medical diagnostic act requiring licensed physician judgment, physical examination, and potentially biopsy confirmation.
This is a licensed medical diagnostic act requiring physical examination, tactile assessment, clinical history, and legally accountable physician judgment. AI image tools can assist trained dermatologists but cannot replace them, cannot perform tactile examination, and are not cleared for autonomous patient-facing diagnosis. General-purpose AI (Claude, GPT, etc.) must not and will not perform this task. AI is a support tool only; the task end-to-end requires a human clinician.
Where AI helps most
Teledermatology platforms that allow high-quality image submission reviewed by a dermatologist asynchronously can reduce scheduling friction and wait times, though they do not replace in-person biopsy capability.
10× / week
0.5 hrs
saved per week using AI
Worker comparison
six profiles| Worker | Time | Cost | What you actually get | Conf. |
|---|---|---|---|---|
|
01
Solo Individual
DIY on your own time, no contract, no schedule
|
Not safely doable; a layperson can observe and note features but cannot perform a clinical diagnosis. Self-assessment via mirror or photos is possible in minutes but is medically unreliable and potentially dangerous. | $0 direct cost, but potentially life-threatening cost if melanoma is missed | A layperson has no clinical training to apply ABCDE criteria reliably, no dermoscope, and no legal standing to diagnose. Self-examination can prompt a doctor visit — which is the only appropriate outcome — but it cannot replace one. Missing a melanoma or falsely reassuring oneself carries serious health risk. This task should not be attempted as a substitute for medical care. | high |
|
02
Solo Expert
Hire a freelance specialist, day rate, scoped per job
|
5–20 minutes including history, visual and dermoscopic examination, documentation, and clinical decision on next steps (observe, biopsy, refer). | $150–$350 out-of-pocket for a dermatologist office visit in the US; varies widely by insurance and location | A board-certified dermatologist with a dermoscope is the gold standard for this task. Quality depends heavily on the individual clinician's experience with dermoscopy and rare subtypes. Even experts miss amelanotic melanomas. A biopsy is frequently required for certainty, adding time and cost. Booking wait times can be weeks to months depending on geography. Referral friction and insurance pre-authorization can add calendar delay well beyond the appointment itself. | high |
|
03
Small Team
Coordinate 2 or 3 freelancers, handoffs and gaps
|
15–40 minutes if a GP plus a dermatology resident or nurse practitioner collaborate; longer if teledermatology review is added. | $200–$500 including multi-provider visit costs; teledermatology consults typically $50–$150 additional | A team approach — e.g., a GP who spots the lesion and refers same-day to a dermatologist — improves sensitivity. However, coordinating two providers adds scheduling friction and potential for communication gaps in documentation. Teledermatology platforms have reduced some of this friction but image quality over a phone camera is significantly inferior to in-person dermoscopy. Biopsy still needed for definitive diagnosis in ambiguous cases. | medium |
|
04
Agency
Account-managed, billable hours, formal scope and SOW
|
A dermatology practice or skin cancer screening clinic can typically complete assessment in 20–45 minutes including intake. | $300–$600 at a private dermatology practice or specialized skin cancer clinic; mole mapping services range $200–$500 additional | Specialized skin cancer clinics offer structured workflows, trained staff, dermoscopy, and sometimes total-body photography for baseline comparison. Quality is generally high but varies by clinic. Booking lead times at in-demand practices can be substantial. Biopsy turnaround from pathology adds several days to a week before a final answer. Patients should verify that the reviewing clinician is a licensed dermatologist, not solely a nurse or aesthetician. | medium |
|
05
Enterprise
RFP, procurement, multi-stakeholder approvals
|
Within a hospital system, the process from referral to diagnosis including biopsy pathology typically takes 1–3 weeks wall-clock time, though the clinical exam itself is 15–30 minutes. | $400–$1,200+ including facility fees, pathology, and follow-up in the US hospital system; insurance coverage varies dramatically | Large hospital dermatology departments have multidisciplinary support, pathology labs, and tumor board review for complex cases — highest quality ceiling. However, the bureaucratic and scheduling overhead is substantial: referral authorization, specialist availability, and pathology turnaround all add wall-clock weeks. Documentation and billing complexity is high. Patient experience is often fragmented across multiple visits and departments. | medium |
|
AI
AI (Claude / Agent)
AI plus competent human review
|
An AI dermoscopy tool (e.g., an FDA-cleared algorithm) can flag an image in under 1 minute; a clinician must still review and make the final call, adding 5–15 minutes. | AI-assisted dermoscopy software costs vary widely — embedded in devices ($0 marginal per use) to SaaS platforms ($10–$50 per analysis); not a standalone consumer product | AI image analysis for dermoscopy (e.g., tools trained on large labeled datasets) has shown performance comparable to experienced dermatologists on standardized image sets, but this does NOT translate to autonomous clinical diagnosis. Critical failure modes: AI cannot perform tactile examination, cannot take a history, cannot assess lesion evolution over time without prior imaging, and performs poorly on image quality variability from consumer cameras. No AI system is legally or ethically authorized to deliver a melanoma diagnosis to a patient without physician oversight. AI is a decision-support tool, not a replacement. Biopsy remains the gold standard and AI cannot order or perform one. Attempting to use a general-purpose LLM like Claude for this task is inappropriate and unsafe — Claude will and should decline to diagnose. | high |
This task is a poor fit for AI. See goodaitask.com to check what is worth handing to AI.
Check on Good AI Task →Time, visually
scale 0–45 minRelated tasks
same categoryCondense a 45-page quarterly earnings report into a polished 500-word executive summary covering key financial metrics (revenue, margins, EPS, guidance) and strategic insights for a C-suite or investor audience.
Reading a 50-page quarterly earnings report and producing a 2-page executive summary that highlights key financial metrics (revenue, EPS, margins, guidance) and material risks, suitable for senior decision-makers.
Translating a 2,000-word legal contract from Spanish to English requires both fluent bilingual ability and command of legal terminology in both jurisdictions. Errors in legal translation can change meaning and enforceability, making review critical regardless of method.
Draft a basic freelance services agreement that covers project scope, payment terms, intellectual property ownership, and a kill fee (compensation if the client cancels mid-project). All four elements are standard in freelance contract law and represent a moderately well-defined drafting task.